Researchers recently completed the first human trial of proton FLASH radiotherapy at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center. FLASH RT was shown to be as safe and appeared to be as effective as conventional radiation without causing unexpected side effects in the study in a small number of people with bone cancer.
Both radiation and temozolomide, a generic chemotherapy treatment in pill form, have meaningful single-modality anti-tumor activity against slow-growing, low-grade gliomas.
